Category: Late Breaking Data

Can a “calculator” really tell doctors who should be on Lipitor?

November 13, 2013- By Steven E. Greer, MD

The AHA released the long-awaited new guidelines that recommend which patients should be on a cholesterol-lowering statin, such as Lipitor or Crestor. The panel of experts incorporated evidence-based medicine into the guidelines, perhaps better than any other medical society guideline panel has done previously. However, the panel also used some very dubious statistical tools as well.

According to Read more »

Increasing rates of double mastectomies in early stage breast cancer

Interviewed by Steven E. Greer, MD

David P. Winchester MD, Medical Director of Cancer Programs for the American College of Surgeons, discusses recent data showing a more than a 100% increase in the rate that young women with early Read more »

Catheter approaches for mitral replacement

March 23, 2014- interviewed by Steven E. Greer, MD

With catheter based methods for replacing the aorta valve not being adopted as expected, the medical device industry is now looking to the mitral valve for hope. Doctors in London and Canada performed Read more »

Interview with MannKind’s CEO, Al Mann, and CFO, Matt Pfeffer.

October 23, 2013- Interviewed by Steven E. Greer, MD

The Healthcare Channel interviewed the CEO of MannKind, Al Mann, and the CFO, Matt Pfeffer. Topics discussed include the latest clinical trial data on inhaled insulin Afrezza and the cash situation. We also discuss Mr. Mann’s other company, Second Sight, which has a Medicare and FDA-approved bionic eye to treat diseases that damage the nerves in the retina.

Super rapid acting insulin and inhaled insulin

CT-scan screening for heart disease fails to show benefit

March 23, 2015- Interviewed by Steven E. Greer, MD

We interviewed the Principal Investigator of the PROMISE trial, Pamela Douglas, MD from Duke. Read more »

CBS promotes outrageous pro-coffee research, again

March 7, 2015- By Steven E. Greer, MD

The coffee industry has been funding mounds of junk science that purport to show the health benefits of drinking coffee, when in fact, coffee is very unhealthy to heart, brain, and blood vessels because Read more »

Daily aspirin once again proves to be of no use and also deadly

Japanese aspirin study

Update January 13, 2015- Yet another study was published highlighting the risks of daily aspirin.  Read more »

Antoni Ribas, MD discusses cancer drugs targeting the PD1 signaling pathways

Interviewed by Steven E. Greer, MD

March 19, 2013

The upcoming ASCO meeting will be dominated by numerous presentations relating to new cancer drugs targeting the cell surface molecule called PD-L1, and the immune cell receptors PD1. Early Phase 1 data in non-small cell lung cancer, renal cancer, and melanoma demonstrated such impressive sustained tumor responses that they papers were published in the New England Journal of Medicine. Antoni Ribas, MD of the UCLA Jonsson Comprehensive Cancer Center is involved in trials testing some of these new molecules. In the video interview, he explains the mechanisms of action, reviews data published so far, and previews new data to be seen at ASCO.

Exclusive: Why did Dr. Nissen resort to secret tapes?

February 23, 2010- By Steven E. Greer, MD

Many in the cardiology community are a bit confused as to why Dr. Steven Nissen Read more »

The CardioMEMS’ heart failure pressure measurement system

By Steven Greer, MD

The CardioMEMS’ heart failure pressure measurement system will be evaluated by Read more »

WordPress Themes

hogan outlet calvin klein baratos calzoncillos calvin klein baratos calzoncillos calvin klein calzoncillos calvin klein ralph lauren canada cheap tiffany calzoncillos calvin klein baratos calvin klein baratos calzoncillos calvin klein calzoncillos calvin klein baratos calzoncillo Calvin Klein hogan outlet online hogan outlet outlet hogan sito ufficiale michael kors uk outlet